ATE350058T1 - Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung - Google Patents

Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung

Info

Publication number
ATE350058T1
ATE350058T1 AT97911582T AT97911582T ATE350058T1 AT E350058 T1 ATE350058 T1 AT E350058T1 AT 97911582 T AT97911582 T AT 97911582T AT 97911582 T AT97911582 T AT 97911582T AT E350058 T1 ATE350058 T1 AT E350058T1
Authority
AT
Austria
Prior art keywords
production
herpes virus
virus composition
mutually protective
mutually
Prior art date
Application number
AT97911582T
Other languages
English (en)
Inventor
Joseph Macek
Karen K Brown
Bobby O Moore
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Application granted granted Critical
Publication of ATE350058T1 publication Critical patent/ATE350058T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97911582T 1996-08-16 1997-08-05 Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung ATE350058T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/698,630 US5853715A (en) 1996-08-16 1996-08-16 Cross-protective equine herpesvirus preparations and method of making and using the same

Publications (1)

Publication Number Publication Date
ATE350058T1 true ATE350058T1 (de) 2007-01-15

Family

ID=24806044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97911582T ATE350058T1 (de) 1996-08-16 1997-08-05 Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung

Country Status (13)

Country Link
US (1) US5853715A (de)
EP (1) EP0929315B1 (de)
JP (1) JP2000516622A (de)
CN (1) CN1228029A (de)
AT (1) ATE350058T1 (de)
AU (1) AU714418B2 (de)
BR (1) BR9711138A (de)
CA (1) CA2263201C (de)
DE (1) DE69737198T2 (de)
DK (1) DK0929315T3 (de)
ES (1) ES2281094T3 (de)
NZ (1) NZ334154A (de)
WO (1) WO1998006427A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02002566A (es) * 1999-09-10 2002-10-23 Akzo Nobel Nv Mutante del virus de herpes equino sensible a la temperatura y vacuna viva del mismo.
EP1129722A1 (de) * 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh GM-negative EHV Mutanten
US6803041B2 (en) * 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
AR040601A1 (es) * 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed Mutantes ehv negativos de gm sin elementos heterologos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
US4083958A (en) * 1976-09-13 1978-04-11 The University Of Kentucky Research Foundation Inactivated equine rhinopneumonitis virus vaccine and use thereof
US4225582A (en) * 1979-03-08 1980-09-30 The University Of Illinois Foundation Vaccine for equine rhinopneumonitis
US5084271B1 (en) * 1984-09-11 1997-08-05 Univ Melbourne Vaccine for equine herpesvirus
DE3852918T2 (de) * 1987-09-28 1995-07-13 Beecham Inc TGEV-Virus vom Schwein als Impfstoff für Hunde.
DE4033446A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Impfstoffe gegen equine herpesviren und ihre herstellung
EP0532833A1 (de) * 1991-05-28 1993-03-24 Miles Inc. Pferde-Rhinopneumonitis Impfstoff
US5741696A (en) * 1992-08-07 1998-04-21 Syntro Corporation Recombinant equine herpesviruses
EP0668355B1 (de) * 1993-12-20 1999-04-07 Akzo Nobel N.V. Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen

Also Published As

Publication number Publication date
CA2263201A1 (en) 1998-02-19
CA2263201C (en) 2008-04-15
JP2000516622A (ja) 2000-12-12
EP0929315A2 (de) 1999-07-21
CN1228029A (zh) 1999-09-08
NZ334154A (en) 2000-07-28
AU4891297A (en) 1998-03-06
EP0929315B1 (de) 2007-01-03
WO1998006427A3 (en) 1998-05-14
DK0929315T3 (da) 2007-04-10
WO1998006427A2 (en) 1998-02-19
ES2281094T3 (es) 2007-09-16
DE69737198T2 (de) 2007-11-08
DE69737198D1 (de) 2007-02-15
BR9711138A (pt) 1999-08-17
US5853715A (en) 1998-12-29
AU714418B2 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
DK0742834T3 (da) Fremgangsmåde til fremstilling af en virusvektor på mindst 20 kb ved intermolekylær homolog rekombination i en prokaryot ce
DK0835930T3 (da) Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV)
DE3486160D1 (de) Modifizierte lebende pseudo-rabies-viren, diese enthaltende impfstoffe gegen pseudo-rabies, verfahren zur herstellung und verfahren zur verwendung derselben.
DE69637642D1 (de) Und kombinierte zusammensetzungen und deren verwendung
DE69431404D1 (de) Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
EP1203817A3 (de) Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose
DE69839737D1 (de) Verfahren zur Herstellung eines hochmolekularen Flockungsmittels
DE69739372D1 (de) Verfahren und zusammensetzungen zur genetisch schützenden und therapeutischen immunisierung
DE3684255D1 (de) Thymidinkinase-deletionsmutanten von bovinem herpesvirus-1, diese enthaltende impfstoffe gegen bovine rhinotracheitis und verfahren zu deren herstellung und verwendung.
DE59809260D1 (de) Verfahren zur Herstellung von niedermolekularen Homopolymerisaten des N-Vinylpyrrolidons
DE69912925D1 (de) Impfstoffzusammensetzung gegen herpes simplex virus und methoden zur verwendung
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
DE60044247D1 (de) Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung
DE59707672D1 (de) Polymerisierbares Phosphazenderivat, Verfahren zu dessen Herstellung und dessen Verwendung
BR9907883A (pt) Composição de vacina, processo para eliciar uma resposta imune a um antìgeno de vìrus de herpes simplex, e, composição imunogênica
BG102809A (en) Vaccine against the reproductive and respiratory syndrome in pigs
DE69530350D1 (de) Verfahren zur Herstellung von Fluor enthaltende Silikon-Zusammensetzung
AU8193191A (en) Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
ES2141093T3 (es) Herpesvirus equinos (ehv) que contienen adn ajeno, procedimiento para su obtencion y su empleo en vacunas.
DE69737198D1 (de) Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung
DE69713040D1 (de) Verfahren zur Herstellung von Cyclopropylacetylen und dessen Derivaten
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
DE69922804D1 (de) Verwendung von polymeren der hyaluronsäure zur mukosalen freigabe von impfstoffen und adjuvantien
DE69401486D1 (de) Verfahren zur Herstellung 2-cyanoimidazol Derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0929315

Country of ref document: EP

REN Ceased due to non-payment of the annual fee